JUPITER NEUROSCIENCES, INC.
JUNS · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Cutler Andrew Jon: Form 4
Insider disclosure · Filed · Report period 31 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- JUNS · 48208B203 - Common Stock, par value $0.0001 per share
Company details and SEC sources
CIK 0001679628 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- JUNS on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 1001 North Us Hwy 1, Suite 504, Jupiter, FL, 33477
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Jupiter Orphan Therapeutics, Inc. (to 05 Dec 2017)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields